Momentum and Meaning in Health-System Pharmacy

In early 2026, health-system pharmacy stands at a defining moment shaped by rising clinical complexity, accelerating scientific innovation, and increasing expectations for access, safety, and outcomes. Pharmacists now play a crucial role beyond medication management: They must interpret the latest medical evidence, apply new policies in real-world practice, and facilitate care models that span the entire health system. This includes hospitals, outpatient clinics, community pharmacies, and retail locations, which are often the most convenient places for patients and their families to receive care.

This March issue of Pharmacy Practice in Focus: Health Systems reflects that expanded role. The articles featured this month highlight how pharmacists contribute across research, safety, prevention, and system design, reinforcing that modern health systems function best when pharmacists are integrated across settings, rather than siloed by site of care.

Particularly, conference coverage further reinforces the importance of evaluating outcomes beyond surface-level metrics. Discussions from the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting & Exhibition challenge assumptions that refill data alone reflect meaningful adherence or improved health outcomes.¹ Evidence presented at the American Heart Association Scientific Sessions demonstrates that adding inclisiran to usual care improves low-density lipoprotein cholesterol control following acute coronary syndrome, supporting more durable lipid management strategies.² Similarly, data shared at IDWeek demonstrate that shingles vaccination is associated with reduced risks of cardiovascular disease, dementia, and all-cause mortality in older adults, reinforcing the value of prevention across the care continuum.³

Beyond the content of this issue, broader trends across health care help explain why the pharmacist’s role continues to expand. Industry analyses from Price Waterhouse Cooper (PWC) show sustained medical cost growth and rising pharmacy expenditures, underscoring the need for more effective medication optimization and stewardship strategies.⁴ At the same time, PwC’s Future of Health analysis projects a shift toward more proactive, digital, and personalized care models over the next decade, trends that align closely with the strengths of health-system pharmacy in preventive care, longitudinal medication management, and population health.⁵

Recent federal policy activity adds another important dimension for health systems. Congress recently passed pharmacy benefit manager (PBM) reform legislation aligned with priorities supported by ASHP and the American Pharmacists Association, focused on transparency and limiting harmful PBM practices.⁶ Although PBMs do not have direct authority over medical benefit payments, their expanding role in formulary preferences, utilization management, and specialty distribution has an increasing impact on health systems that manage outpatient, specialty, and infusion pharmacy services.

Importantly, pharmacists across all sectors of practice contribute to this evolving landscape. Community and retail pharmacies, many of which operate within or alongside health-system networks, serve as accessible care hubs for patients and neighbors. These settings play a critical role in prevention, chronic disease follow-up, and continuity of care, particularly in rural and underserved communities, reinforcing that health-system pharmacy does not end at the hospital door.⁷

Health-system pharmacists have already demonstrated proof of concept. Programs in antimicrobial stewardship, transitions-of-care medication reconciliation, heart failure optimization, ambulatory chronic disease management, and glucagon-like peptide-1 therapy stewardship consistently show that when pharmacists are empowered, variability decreases, safety improves, and outcomes follow. These models have opened the door for expanded clinical opportunities by demonstrating measurable value, rather than theoretical potential.

Health systems continue to face workforce constraints and rising operational demands. Doing more with less cannot be achieved by simply adding responsibilities. Sustainable progress requires redesigning workflows, leveraging technology such as clinical decision support and analytics, and aligning responsibilities with clinicians best prepared to manage medication complexity. Yet, technology alone is insufficient. Clear policy pathways, equitable reimbursement, and standardized clinical authority remain essential to sustaining preventive and proactive pharmacy services.

As the profession advances, health-system pharmacy's future depends on intentional leadership, disciplined action, and a commitment to patient outcomes. The work featured in this issue reflects a profession that is not reacting to change but actively shaping the future of care.

REFERENCES

1. Silvius L. Refill metrics versus real outcomes: when medication adherence does not equal improved health. Pharmacy Times. December 23, 2025. Accessed February 1, 2026. https://www.pharmacytimes.com/view/refill-metrics-vs-real-outcomes-when-medication-adherence-doesn-t-equal-better-health

2. Ferruggia K. Effect of inclisiran on low-density lipoprotein cholesterol after acute coronary syndrome. Pharmacy Times. November 10, 2025. Accessed February 1, 2026. https://www.pharmacytimes.com/view/inclisiran-plus-usual-care-enhances-ldl-c-control-post-acute-coronary-syndrome

3. Halpern L. Association of herpes zoster vaccination with reduced risk of cardiovascular disease, dementia, and mortality in older adults. Pharmacy Times. January 14, 2026. Accessed February 1, 2026. https://www.pharmacytimes.com/view/shingles-vaccination-lowers-risk-of-heart-disease-dementia-and-death-in-older-adults

4. PwC Health Research Institute. No let up in sight. medical cost trend set to grow at 8.5%. is your playbook ready? July 16, 2025. Accessed February 1, 2026. https://www.pwc.com/us/en/industries/health-industries/library/behind-the-numbers.html

5. PwC Health Research Institute. From breaking point to breakthrough: the $1 trillion opportunity to reinvent healthcare. September 17, 2025. Accessed February 1, 2026. https://www.pwc.com/us/en/industries/health-industries/library/future-of-health.html

6. American Society of Health-System Pharmacists. Congress passes PBM legislation aligned with ASHP priorities. February 3, 2026. Accessed February 4, 2026. https://news.ashp.org/News/ashp-news/2026/02/03/breaking-news-congress-passes-pbm-legislation-aligned-with-ashp-priorities

7. National Community Pharmacists Association. Oz on AI and the accessibility of pharmacies. Published January 30, 2026. Accessed February 1, 2026. https://ncpa.org/newsroom/qam/2026/01/30/oz-ai-and-accessibility-pharmacies